Trial Profile

A Controlled Clinical Trial of Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Saxagliptin (Primary)
Indications Diabetic foot ulcer
Focus Therapeutic Use

Most Recent Events

06 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Nov 2017.
06 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2017.
13 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Jul 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com